| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;113:2943-2946.)
© 2006 American Heart Association, Inc.
ADA/AHA Scientific Statement |
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
Overweight or obesity results in a wide range of elevated risk factors and many fatal and nonfatal conditions.4 Paradoxically, although we have witnessed decades in which heart disease and stroke have steadily declined and cancer mortality has at worse remained stable,5 the prevalence of diabetes has soared.6 The increase in diabetes can largely be attributed to weight gain,7,8 and it threatens the enormous advances in disease prevention we have seen.3,9,10
Among individuals with diabetes, cardiovascular disease (CVD) is the leading cause of morbidity and mortality9,11; adults with diabetes have a two- to fourfold higher risk of CVD compared with those without diabetes.12,13 Diabetes is also accompanied by a significantly increased prevalence of hypertension and dyslipidemia.14
It is reasonable to postulate that in many individuals, excess weight gives rise to diabetes, hypertension, and dyslipidemia, thereby leading to frank CVD.1517 This seemingly simple algorithm is undoubtedly more complex because (1) many studies show that
This article has been cited by other articles:
![]() |
J. M. Edwards, Z. P. Neeb, M. A. Alloosh, X. Long, I. N. Bratz, C. R. Peller, J. P. Byrd, S. Kumar, A. G. Obukhov, and M. Sturek Exercise training decreases store-operated Ca2+entry associated with metabolic syndrome and coronary atherosclerosis Cardiovasc Res, October 4, 2009; (2009) cvp308v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Wright Jr, J. L. Probstfield, W. C. Cushman, S. L. Pressel, J. A. Cutler, B. R. Davis, P. T. Einhorn, M. Rahman, P. K. Whelton, C. E. Ford, et al. ALLHAT Findings Revisited in the Context of Subsequent Analyses, Other Trials, and Meta-analyses Arch Intern Med, May 11, 2009; 169(9): 832 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Amundson, M. K. Butcher, D. Gohdes, T. O. Hall, T. S. Harwell, S. D. Helgerson, K. K. Vanderwood, and for the Montana Cardiovascular Disease and Diabete Translating the Diabetes Prevention Program Into Practice in the General Community: Findings From the Montana Cardiovascular Disease and Diabetes Prevention Program The Diabetes Educator, March 1, 2009; 35(2): 209 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
Needs Assessment The Diabetes Educator, March 1, 2008; 34(Supplement_2): 30S - 31S. [Full Text] [PDF] |
||||
![]() |
L. B. Haas The Role of the Diabetes Educator: Patient Case Scenarios The Diabetes Educator, March 1, 2008; 34(Supplement_2): 32S - 36S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hollander Cardiometabolic Risk Factors and Visceral Adipose Tissue The Diabetes Educator, March 1, 2008; 34(Supplement_2): 37S - 41S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Wright Jr, S. Harris-Haywood, S. Pressel, J. Barzilay, C. Baimbridge, C. J. Bareis, J. N. Basile, H. R. Black, R. Dart, A. K. Gupta, et al. Clinical Outcomes by Race in Hypertensive Patients With and Without the Metabolic Syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Arch Intern Med, January 28, 2008; 168(2): 207 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pedro-Botet Review: The role of fenofibrate in reducing cardiovascular risk in type 2 diabetes The British Journal of Diabetes & Vascular Disease, January 1, 2008; 8(1): 22 - 27. [Abstract] [PDF] |
||||
![]() |
R. Bentley-Lewis, G. K. Adler, T. Perlstein, E. W. Seely, P. N. Hopkins, G. H. Williams, and R. Garg Body Mass Index Predicts Aldosterone Production in Normotensive Adults on a High-Salt Diet J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4472 - 4475. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157. [Full Text] [PDF] |
||||
![]() |
M. A. Marini, E. Succurro, S. Frontoni, M. L. Hribal, F. Andreozzi, R. Lauro, F. Perticone, and G. Sesti Metabolically Healthy but Obese Women Have an Intermediate Cardiovascular Risk Profile Between Healthy Nonobese Women and Obese Insulin-Resistant Women Diabetes Care, August 1, 2007; 30(8): 2145 - 2147. [Full Text] [PDF] |
||||
![]() |
S. Cook and S. S. Gidding Modifying Cardiovascular Risk in Adolescent Obesity Circulation, May 1, 2007; 115(17): 2251 - 2253. [Full Text] [PDF] |
||||
![]() |
L. W. Johnson and R. S. Weinstock The Metabolic Syndrome: Concepts and Controversy Mayo Clin. Proc., December 1, 2006; 81(12): 1615 - 1620. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |